Skip to main content
. 2017 Aug 1;7:7026. doi: 10.1038/s41598-017-06268-y

Table 2.

NOD2 genotypes and clinical course in SC-CIP patients (Cohort 1).

NOD2 status Wild-type Variants*
Patients (%) 12/17 (70.6%) 5/17 (29.4%)
Cholangitis 4/12 (33.3%) 4/5 (80.0%)
Sepsis 7/12 (58.3%) 3/5 (60.0%)
Progression to cirrhosis 5/12 (41.7%) 3/5 (60.0%)
Liver transplantation 0 2/5 (40.0%)
Death 3/12 (25%) 0

*4 patients were carriers of the NOD2 variant p.R702W, and one patient carried

the c.3020insC variant, all in heterozygous state.